Clinical Trials Sponsored by BioFirst Corporation
Total 6480 results
-
AmpliMed CorporationCompletedNeoplasm MetastasisUnited States
-
Cordis CorporationCompleted
-
Guidant CorporationCompletedCongestive Heart FailureFrance
-
Cordis CorporationCompletedCoronary Artery DiseaseNetherlands
-
Guidant CorporationTerminated
-
Corixa CorporationUnknownNon-Small Cell Lung CancerUnited States
-
Celgene CorporationCompletedBreast Neoplasms | Metastases, NeoplasmUnited States
-
Chiron CorporationCompletedAdenocarcinoma | Stomach Neoplasms | Esophageal NeoplasmsUnited States
-
Chiron CorporationCompletedLymphoma, Non-HodgkinUnited States
-
Chiron CorporationTerminatedNon-Hodgkin LymphomaUnited States
-
Chiron CorporationUnknownMeningococcal Disease; Meningococcal MeningitisUnited Kingdom
-
Repligen CorporationTerminated
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Theragenics CorporationUnknownMacular Degeneration | Choroidal NeovascularizationUnited States
-
Mannkind CorporationNot yet recruitingMycobacterium Infections, Nontuberculous | MAC Lung Disease | Treatment Refractory MAC Lung DiseaseUnited States
-
Pulmonx CorporationRecruiting
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaSwitzerland, Germany, Ukraine, United Kingdom
-
Yuhan CorporationRecruitingEssential HypertensionKorea, Republic of
-
Incyte CorporationRecruitingPregnancy Related | Atopic DermatitisUnited States
-
Incyte CorporationRecruiting
-
Omeros CorporationRecruitingC3 Glomerulopathy | Idiopathic Immune Complex-Mediated GlomerulonephritisLithuania, New Zealand, Poland, Tunisia, Turkey, United Kingdom
-
Bionime CorporationNot yet recruiting
-
Glaukos CorporationRecruitingOcular Hypertension | Open Angle GlaucomaUnited States
-
Masimo CorporationRecruiting
-
Glaukos CorporationRecruitingOcular Hypertension | Open Angle GlaucomaArmenia
-
Incyte CorporationRecruitingMyeloproliferative NeoplasmsUnited States
-
Omeros CorporationRecruitingParoxysmal Nocturnal HemoglobinuriaGermany, Greece, Switzerland, United Kingdom
-
Incyte CorporationRecruitingCutaneous Squamous Cell CarcinomaUnited States, Korea, Republic of, Spain, Brazil, France, Turkey, Canada, Mexico, Chile, Australia, Romania, South Africa, Colombia, Finland, Hungary, Montenegro, New Zealand, Croatia, Netherlands, North Macedonia
-
Incyte CorporationRecruitingPrurigo NodularisKorea, Republic of, Spain, United States, Poland, Italy, Australia, Austria, Germany, Canada, Switzerland, France, Denmark, Bulgaria
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Yuhan CorporationRecruitingCoronary Artery Disease | Peripheral Arterial Disease | Blood Viscosity | SarpogrelateKorea, Republic of
-
QurAlis CorporationRecruitingAmyotrophic Lateral SclerosisCanada, Germany, Netherlands, Ireland, United Kingdom, Belgium
-
Incyte CorporationRecruitingHidradenitis Suppurativa (HS)United States, Canada, Czechia, Spain, Germany, Poland, Netherlands, Belgium, France, Greece, Japan, Austria
-
Immuneering CorporationRecruitingPancreatic Adenocarcinoma | Advanced Solid Tumor | Non-small Cell Lung Cancer (NSCLC) | Malignant Melanoma (Cutaneous)United States
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
Incyte CorporationRecruitingSolid TumorsUnited States, Japan, France, Italy, United Kingdom, Netherlands, Switzerland
-
NaviFUS CorporationRecruitingDrug Resistant EpilepsyTaiwan
-
NaviFUS CorporationRecruitingRecurrent GlioblastomaTaiwan
-
Incyte CorporationRecruitingAnemia | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, France, Italy, Japan, United Kingdom, Canada
-
Ionetix CorporationRecruitingMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesUnited States
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada
-
Revalesio CorporationNot yet recruitingAmyotrophic Lateral Sclerosis
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Incyte CorporationCompletedPrurigo NodularisUnited States, Canada, Germany, Poland, Puerto Rico, Spain
-
Geron CorporationActive, not recruitingMyelodysplastic SyndromesUnited States, Canada, Belgium, Spain, Czechia, Korea, Republic of, United Kingdom, Netherlands, Israel, Germany, Russian Federation, Switzerland, Italy, France, Turkey, Poland, Ukraine
-
Incyte CorporationActive, not recruitingMPN (Myeloproliferative Neoplasms)United States, France, United Kingdom, Spain, Canada, Japan, Germany, Switzerland, Belgium, Austria, Italy
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
Incyte CorporationCompletedVitiligoUnited States, Canada, France